NervGen Pharma Corp.
Ownership
Ownership Structure
Who owns NervGen Pharma Corp. (NGEN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.6% of the shares are freely tradable; institutional investors hold 5.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Empery Asset Management, LP | 3.72 | 4,000,000 | +0.0 | 06/30/2026 |
| Rock Springs Capital Management LP | 1.12 | 1,208,231 | +0.0 | 06/30/2026 |
| Dafna Capital Management LLC | 0.98 | 1,050,000 | +0.0 | 06/30/2026 |
| Ghisallo Capital Management LLC | 0.93 | 1,000,000 | +0.0 | 06/30/2026 |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 0.78 | 834,156 | +8,241.6 | 09/30/2026 |
| Armistice Capital, LLC | 0.63 | 678,000 | +0.0 | 06/30/2026 |
| LMR Partners LLP | 0.56 | 600,000 | +0.0 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 0.41 | 435,962 | +117.6 | 06/30/2026 |
| UBS Group AG | 0.35 | 379,726 | +517.3 | 06/30/2026 |
| Stonepine Capital Management Llc | 0.25 | 271,678 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.